| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |